Old Web
English
Sign In
Acemap
>
Paper
>
JAK2 V617F mutation testing in polycyhemia vera and polycythemia vera-like disease: impact on thrombotic risk.
JAK2 V617F mutation testing in polycyhemia vera and polycythemia vera-like disease: impact on thrombotic risk.
2014
Rossella R. Cacciola
Elisa Seria
Maria Torre
Emma Cacciola
Keywords:
Mutation testing
JAK2 V617F
Biology
Immunology
Disease
Polycythemia vera
thrombotic risk
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]